Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BeOne Medicines Ltd. - American Depositary Shares (NQ:ONC)

341.80 +23.07 (+7.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 357,605
Open 338.49
Bid (Size) 341.80 (1)
Ask (Size) 341.97 (3)
Prev. Close 318.73
Today's Range 335.75 - 341.99
52wk Range 172.67 - 339.86
Shares Outstanding 1,211,067,023
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga

Performance

YTD
+85.8%
+85.8%
1 Month
+11.3%
+11.3%
3 Month
+33.0%
+33.0%
6 Month
+33.0%
+33.0%
1 Year
+85.8%
+85.8%

More News

Read More
BeOne Medicines Stock Gains Momentum With Early-Stage Trial Success For Pretreated Lymphoma Patients
Via Benzinga
A Glimpse of BeiGene's Earnings Potential
Via Benzinga
Earnings Scheduled For August 6, 2025
Via Benzinga
BeiGene's Earnings: A Preview
Via Benzinga
Affirm Posts Better-Than-Expected Earnings, Joins Ambarella, IREN, Petco Health and Wellness And Other Big Stocks Moving Higher On Friday
Via Benzinga
BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
From BeOne Medicines Ltd.
Via Business Wire
European Commission Approves TEVIMBRA® as Neoadjuvant/Adjuvant NSCLC Treatment Ahead of Late-Breaking Data Presentation at WCLC 2025
From BeOne Medicines Ltd.
Via Business Wire
BeOne to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
From BeOne Medicines Ltd.
Via Business Wire
BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up
Via Benzinga
BeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 Million
From BeOne Medicines Ltd.
Via Business Wire
European Commission Approves Tablet Formulation of BeOne Medicines’ BRUKINSA® for All Approved Indications
From BeOne Medicines Ltd.
Via Business Wire
Earnings Scheduled For August 8, 2025
Via Benzinga
BeOne Medicines (ONC) Q2 EPS Soars 924%
Via The Motley Fool
BeOne Medicines Announces Second Quarter 2025 Financial Results and Business Updates
From BeOne Medicines Ltd.
Via Business Wire
BeOne Medicines Receives PRIME Designation from the European Medicines Agency for BGB-16673 in Waldenstrom’s Macroglobulinemia
From BeOne Medicines Ltd.
Via Business Wire
BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Neoadjuvant/Adjuvant NSCLC Treatment
From BeOne Medicines Ltd.
Via Business Wire
Deep Dive Into BeOne Medicines Stock: Analyst Perspectives (9 Ratings)
Via Benzinga
BeOne Medicines to Announce Second Quarter 2025 Financial Results on August 6
From BeOne Medicines Ltd.
Via Business Wire
European Commission Approves TEVIMBRA® in Combination with Chemotherapy as a First-Line Treatment for Nasopharyngeal Carcinoma
From BeOne Medicines Ltd.
Via Business Wire
AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment
Via Benzinga
What 8 Analyst Ratings Have To Say About BeOne Medicines
Via Benzinga
BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day
From BeOne Medicines Ltd.
Via Business Wire
BeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA®
From BeOne Medicines Ltd.
Via Business Wire

Frequently Asked Questions

Is BeOne Medicines Ltd. - American Depositary Shares publicly traded?
Yes, BeOne Medicines Ltd. - American Depositary Shares is publicly traded.
What exchange does BeOne Medicines Ltd. - American Depositary Shares trade on?
BeOne Medicines Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for BeOne Medicines Ltd. - American Depositary Shares?
The ticker symbol for BeOne Medicines Ltd. - American Depositary Shares is ONC on the Nasdaq Stock Market
What is the current price of BeOne Medicines Ltd. - American Depositary Shares?
The current price of BeOne Medicines Ltd. - American Depositary Shares is 341.80
When was BeOne Medicines Ltd. - American Depositary Shares last traded?
The last trade of BeOne Medicines Ltd. - American Depositary Shares was at 09/05/25 04:00 PM ET
What is the market capitalization of BeOne Medicines Ltd. - American Depositary Shares?
The market capitalization of BeOne Medicines Ltd. - American Depositary Shares is 413.94B
How many shares of BeOne Medicines Ltd. - American Depositary Shares are outstanding?
BeOne Medicines Ltd. - American Depositary Shares has 414B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.